articleNatureSep 26, 2017GREEN OA

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

AbbVie (United States) · Fate Therapeutics (United States) · +7 more institutions

PubMed
Indexed incrossrefdatacitepubmed

Abstract

No abstract available for this paper.

Citation impact

843
total citations
FWCI
26.69
Percentile
100%
References
23
Citations per year

Authors

39

Topics & keywords

Keywords
  • Lineage (genetic)
  • Computational biology
  • Drug discovery
  • Chemistry
  • Biology
  • Genetics
  • Bioinformatics
  • Gene
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.